Drug Shortage Report for CLINDAMYCIN INJECTION USP
Report ID | 234803 |
Drug Identification Number | 02230535 |
Brand name | CLINDAMYCIN INJECTION USP |
Common or Proper name | CLINDAMYCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 150MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 60ML |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-08-30 |
Actual start date | |
Estimated end date | |
Actual end date | 2024-08-23 |
Shortage status | Avoided shortage |
Updated date | 2024-08-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-08-23 | French | Compare |
v5 | 2024-08-23 | English | Compare |
v4 | 2024-08-21 | French | Compare |
v3 | 2024-08-21 | English | Compare |
v2 | 2024-08-08 | French | Compare |
v1 | 2024-08-08 | English | Compare |
Showing 1 to 6 of 6